Vivian Tsang is a pharmacist who is specialized in Oncology in West Hollywood, California. Patients can reach her at 8700 Beverly Blvd, A845, West Hollywood or contact her on 310-423-5510. Active license number of Vivian Tsang is 58933 for Oncology in California. Vivian Tsang is a licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.
Complete Profile:
Vivian Tsang speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Vivian Tsang
Specialization:
Oncology
Credentials:
PHARM.D.
Gender:
Female
Location:
8700 Beverly Blvd, A845, West Hollywood, California, 90048-1804
Phone:
310-423-5510
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Vivian Tsang are as mentioned below.
NPI Number:
1962600627
NPI Enumeration Date:
04 Jul, 2007
NPI Last Update On:
16 Jun, 2009
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Vivian Tsang are as mentioned below.
Specialization
License Number
State
Status
Oncology
58933
California
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
8700 Beverly Blvd # A845, Los Angeles, California
Zip:
90048-3604
Phone Number:
310-423-5510
Fax Number:
--
Patients can reach Vivian Tsang at 8700 Beverly Blvd, A845, West Hollywood, California or can call on phone at 310-423-5510.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.